Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Acute Gastroenteritis May Lead to Heart Disease

By LabMedica International staff writers
Posted on 09 Dec 2010
People who become infected with Escherichia coli have a higher risk of subsequently developing hypertension, heart disease, and kidney problems. More...


Individuals who have become infected with E. coli 0157:H7 and/or Campylobacter and suffered from acute gastroenteritis may have an increased risk of chronic diseases associated with high blood pressure and renal impairment.

An assessment was made at Victoria Hospital, (London, Ontario, Canada), of 4,561 people who had been exposed to a tainted municipal water system in May 2000. The water had been infected with Campylobacter and E. coli 0157:H7 bacteria. The long-term health of 1,977 individuals who had developed gastroenteritis was evaluated as 1,067 of them became ill with acute gastroenteritis, and 378 sought help from a physician. Of the 131 stool samples tested for pathogens, 19% were positive for E. coli O157:H7, 19% were positive for Campylobacter, and 1.5% showed coinfection. This prospective cohort study was conducted from 2002 until 2008.

Structural and functional renal impairment were defined as microalbuminuria (albumin:creatinine ratio greater than 2.0 mg/mmol in men and more than 2.8 mg/mmol in women) and estimated glomerular filtration rate less than 60 mL/min/1.73 m2, respectively. Two classifications of renal impairment were analyzed: the presence of either indicator of renal impairment and the presence of both indicators.

The investigators discovered that those who had developed gastroenteritis symptoms had a 1.3 higher risk of developing hypertension (high blood pressure) compared to those who had not become infected. Renal impairment (kidney problem) risk was 3.4 times higher, and the chances of having a cardiovascular event, such as stroke or heart attack were 2.1 times higher. Recent research suggests that the presence of both structural and functional renal impairment is a stronger predictor of mortality, cardiovascular morbidity, and renal decline than either structural or functional renal impairment alone.

The authors concluded that their findings underline the need for following up individual cases of food or water poisoning by E. coli O157:H7 to prevent or reduce silent progressive vascular injury. These long-term consequences emphasize the importance of ensuring safe food and water supply as a cornerstone of public health.

The study was published November 17, 2010, in the British Medical Journal.

Related Links:

Victoria Hospital


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.